Clinical Trial Update: Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System [NA]

View source ↗

Summary

Clinical trial update for hyperopia correction using the Opti-K system; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperopia

Drugs mentioned

• Opti-K

Snippet

Sponsor: NTK Enterprises, Inc. | Conditions: Hyperopia | NA | Status: TERMINATED | Results posted: 2019-05-09